Celcuity Inc. (CELC) Fundamentals

Celcuity Inc is clinical-stage biotechnology company seeking to extend the lives of cancer patients by pursuing an integrated therapeutic (Rx) and companion diagnostic (CDx) strategy. The company's drug candidate, gedatolisib, is a potent, well-tolerated, small molecule dual inhibitor, administered intravenously, that selectively targets all class I isoforms of PI3K and mammalian target of rapamycin (mTOR).
SHARE INFORMATION
Market CapUS$ 156.136.940
Shares Outstanding14.941.334
Float10.561.502
Percent Float70,69%
Short Interest0,00
Short Percent Float0,0%
Short Interest Ratio0,00
Short Interest Date-
Latest Fiscal Dividend Per ShareUS$ 0,00
Latest Fiscal RevenueUS$ 0
Latest Fiscal EPSUS$ -2,20
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)US$ 0,00
Dividend (5 Years)US$ 0,00
Ex Dividend Date-
Dividend RateUS$ 0,00
Dividend Yield0,0%
Payment Cash-
HOLDERS
Institutions139
Institutional Holdings Date2022-07-31
Institutional Bought Previous 3 Months433.454
Institutional Holdings Percent40,9%
Institutional Sold Previous 3 Months956.525
Insider Holdings Date2022-07-31
Insider Bought Previous 3 Months1.044.230
Insider Holdings Percent27,7
Insider Sold Previous 3 Months356.953
Insider Shares Owned4.137.353
TRADING INFO
52 Week HighUS$ 23,11
52 Week LowUS$ 4,81
52 Week High ChangeUS$ -50,21
21 Day Moving AverageUS$ 9,4219
21 Day Extended Moving AverageUS$ 9,3985
50 Day Moving AverageUS$ 8,5928
50 Day Extended Moving AverageUS$ 8,843
200 Day Moving AverageUS$ 10,6414
200 Day Extended Moving AverageUS$ 10,6825
10 Day Average Volume76.465
20 Day Average Volume79.602
30 Day Average Volume109.178
50 Day Average Volume95.142
Alpha0.006533
Beta1.2196
Standard Deviation0.243843
R20.064701
7 Day Price ChangeUS$ 1,37
7 Day Percent Change15,09%
21 Day Price ChangeUS$ 1,13
21 Day Percent Change12,12%
30 Day Price ChangeUS$ 1,49
30 Day Percent Change16,63%
Month to Date Price ChangeUS$ 1,37
Month to Date Percent Change15,09%
Quarter to Date Price ChangeUS$ 1,35
Quarter to Date Percent Change14,84%
180 Day Price ChangeUS$ -0,41
180 Day Percent Change-3,78%
200 Day Price ChangeUS$ -1,08
200 Day Percent Change-9,37%
Year to Date Price ChangeUS$ -2,74
Year to Date Percent Change-20,77%

Celcuity Inc. (CELC) Key Ratios

PROFITABILITY
EBIT Margin0,0%
EBITDA Margin0,0%
Pre-Tax Profit Margin0,0%
Profit Margin Count0,0%
Gross Margin0,0%
Profit Margin TOT0,0%
INCOME STATEMENTS
RevenueUS$ 0
Revenue Per ShareUS$ 0,00
Revenue (3 Years)US$ 0,00
Revenue (5 Years)US$ 0,00
FINANCIAL STRENGTH
Price to Tangible Book2,50
Total Debt To Equity0,20
Int Coverage-19,50
Current Ratio22,40
Leverage Ratio1,30
Quick Ratio22,10
Long Term Debt To Capital0,19
VALUATION MEASURES
PE Ratio-4,20
Enterprise ValueUS$ 92.875.971
Price to Sales0,00
Price to Free Cash-9,70
PE High Last 5 Years-17,60
Price To Book2,50
Price To Cash Flow0,00
PE Low Last 5 Years-21,30
Price to Tangible Book2,50
MANAGEMENT EFFECTIVENESS
Receivables Turnover0,00
Invoice Turnover0,00
Assets Turnover0,00
Return Assets-59,76
Return on Equity-71,86
Return on Capital-59,08

Celcuity Inc. (CELC) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorBoulay PLLP
CEOBrian F. Sullivan
Emplyoees39
Last AuditUQ
CIK0001603454
IndustryBiotechnology
SectorHealthcare
NAICSResearch and Development in Biotechnology (except Nanobiotechnology)(541714)
CONTACT INFO
Address16305 36th Avenue North
Suite 100
Minneapolis, MN 55446
Websitehttps://www.celcuity.com
Facsimile-
Telephone+1 763 392-0767
Emailbsullivan@celcuity.com
Seu Histórico Recente
NASDAQ
CELC
Celcuity
Registre-se agora para acompanhar essas ações ao vivo no Monitor ADVFN.

O Monitor permite ver até 110 de suas ações favoritas de uma vez só e é completamente grátis para você usar.

Faça o login em ADVFN
Registrar agora
Cotações da NYSE e AMEX têm defasagem de no mínimo 20 minutos.
Quaisquer outras cotações têm defasagem de no mínimo 15 minutos quando não especificado.
Em caso de dúvidas por favor entre em contato com o suporte: suporte@advfn.com.br ou (11) 4950 5808.

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

P: V:br D:20220808 07:21:53